First Trust Capital Management
CTOR icon

First Trust Capital Management’s Citius Oncology CTOR Stock Holding History

First Trust Capital Management’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-373,806
Closed -$4.13M – 110
2024
Q1 		$4.13M Buy
+373,806
New +$4.11M 0.35% 72

Other funds holding CTOR

Cowen and Company
Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return
W.R. Berkley Corp
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Rivernorth Capital Management
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Mizuho Securities USA
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Westchester Capital Management (New York)
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Logan Stone Capital
Logan Stone Capital Chicago, Illinois $473M AUM 0.79% 1-Year Est. Return
Yakira Capital Management
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

First Trust Capital Management's CTOR Position: Q2 2024 in Review

First Trust Capital Management sold out of Citius Oncology (CTOR) in Q2 2024, closing a stake of 373,806 shares — an estimated $4.13M sold.

First Trust Capital Management first reported a position in CTOR in Q1 2024 and held it in 1 quarter. The position peaked at $4.13M in Q1 2024. 13 funds tracked by Wall St. Rank hold CTOR as of Q2 2024.

  • First Trust Capital Management reported no remaining Citius Oncology position as of Q2 2024 after selling out during the quarter.
  • First Trust Capital Management sold 373,806 Citius Oncology shares in Q2 2024, an estimated $4.13M.
  • First Trust Capital Management first reported a position in Citius Oncology in Q1 2024 and held it in 1 quarter.
  • First Trust Capital Management's Citius Oncology position peaked at $4.13M in Q1 2024.
  • 13 funds tracked by Wall St. Rank held Citius Oncology as of Q2 2024.

Based on First Trust Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.